LONA Earnings — LeonaBio, Inc. Common Stock Post-ER Performance | BigEarnings
LONA — LeonaBio, Inc. Common Stock
XNAS
Price$9.54
Market Cap$89.6M
P/E—
52W Range$4.21 – $14.21
Next Earnings2026-08-06
About LeonaBio, Inc. Common Stock
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.
